Vanta Bioscience Limited
VANTABIO
Rank in Stocks
#32441
Vanta Bioscience Limited functions as an all-encompassing preclinical contract... Vanta Bioscience Limited functions as an all-encompassing preclinical contract research organization (CRO). The firm extends a wide array of specialized offerings, including Discovery Toxicology, comprehensive assessments for Agro-Chemicals and overall Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Testing. This company commenced operations on April 29, 2016, and its main office is situated in Hyderabad, India.
Share Price
$0.2114946
Last synced: 2026-11-13
Market Cap
$1.50M
Change (1 day)
-0.17%
Change (1 year)
-20.20%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vanta Bioscience Limited (VANTABIO)
Category
Healthcare
Operating Margin for Vanta Bioscience Limited (VANTABIO)
Operating Margin as of November 2026 TTM: 41.78%
According to Vanta Bioscience Limited's latest financial reports, its current operating margin (TTM) is 41.78%. At the end of 2025 the company had an operating margin of -441.65%.
Operating Margin history for Vanta Bioscience Limited from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 41.78% | -109.46% |
| 2025 | -441.65% | 1,248.55% |
| 2024 | -32.75% | -62.30% |
| 2023 | -86.88% | -479.22% |
| 2022 | 22.91% | -18.15% |
| 2021 | 27.99% | 21.06% |
| 2020 | 23.12% | -7.37% |
| 2019 | 24.96% | 75.90% |
| 2018 | 14.19% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 33.87% | -99.19% |
US
|
|
| -116.04% | -102.78% |
US
|
|
| 25.57% | -99.39% |
AU
|
|
| 31.23% | -99.25% |
BE
|
|
| 29.35% | -99.30% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Vanta Bioscience Limited's operating margin
What is Vanta Bioscience Limited's operating margin?
Vanta Bioscience Limited's operating margin is 41.78%, as of Nov 2026.
What was Vanta Bioscience Limited's operating margin in 2025?
In 2025, Vanta Bioscience Limited's operating margin was -441.65%, compared with -32.75% in 2024.
How has Vanta Bioscience Limited's operating margin changed since 2020?
From 2020 to 2025, Vanta Bioscience Limited's operating margin was highest in 2021 (27.99%) and lowest in 2025 (-441.65%).
How does Vanta Bioscience Limited's operating margin compare with similar companies?
Vanta Bioscience Limited's operating margin (41.78%) is higher than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.